2021
DOI: 10.1002/cnr2.1351
|View full text |Cite
|
Sign up to set email alerts
|

Cortisol promotes breast‐to‐brain metastasis through the blood‐cerebrospinal fluid barrier

Abstract: Background: Elevated basal cortisol levels are present in women with primary and metastatic breast cancer. Although cortisol's potential role in breast-to-brain metastasis has yet to be sufficiently studied, prior evidence indicates that it functions as a double-edged sword-cortisol induces breast cancer metastasis in vivo, but strengthens the bloodbrain-barrier (BBB) to protect the brain from microbes and peripheral immune cells.Aims: In this study, we provide a novel examination on whether cortisol's role in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
6
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

4
2

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 28 publications
1
6
0
Order By: Relevance
“…Correspondingly, we also observe enhanced tumor infiltration across the BCSFB compared to the BBB in mice treated with chemotherapy. This discovery on the impact of chemotherapy on BCSFB further supports previous reports on the preferential route of breast cancer entry into the brain via the BCSFB (Herrera et al, 2022). Therefore, given our results, the increased CTC numbers seen after chemotherapy (Ortiz‐Otero et al, 2020), and the positional proximity of the ventricles to CSF circulation in the brain (Lun et al, 2015), it is important to consider the BCSFB as a vulnerable early point of CNS‐entry for chemo‐treated breast cancer cells.…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…Correspondingly, we also observe enhanced tumor infiltration across the BCSFB compared to the BBB in mice treated with chemotherapy. This discovery on the impact of chemotherapy on BCSFB further supports previous reports on the preferential route of breast cancer entry into the brain via the BCSFB (Herrera et al, 2022). Therefore, given our results, the increased CTC numbers seen after chemotherapy (Ortiz‐Otero et al, 2020), and the positional proximity of the ventricles to CSF circulation in the brain (Lun et al, 2015), it is important to consider the BCSFB as a vulnerable early point of CNS‐entry for chemo‐treated breast cancer cells.…”
Section: Discussionsupporting
confidence: 89%
“…The current prevailing model is that metastatic cancer cells enter the brain by crossing the BBB. However, we recently showed breast cancer cells have a preference for crossing the BCSFB (Herrera et al, 2022). First, to determine whether systemic chemotherapy opens the entry barriers of the brain, we set up an in vivo model of acute and delayed chemotherapeutic response.…”
Section: Resultsmentioning
confidence: 99%
“… 65 Recent in vitro studies show that while LC cells migrate through the BBB and BCSFB at comparable rates, breast cancer cells preferentially migrate through the BCSFB by degrading TJs in the choroid epithelium. 66 Neuroblastoma cells were able to migrate across an intact BCSFB in a paracellular fashion within 24 hours in vitro, without affecting the integrity of choroid epithelium. 67 …”
Section: Tumor Microenvironmentmentioning
confidence: 95%
“…Thus, the CNS must be protected from external influences at interfaces where blood and cerebral spinal fluid (CSF) come into close contact with neural elements. Intriguingly, Herrera et al describe how cortisol, a stress hormone, promotes breast to brain metastasis through the blood–CSF barrier 5 . Moreover, Remsik et al demonstrate that breast and lung tumor cells adopt a two‐phenotypic state in in leptomeningeal disease when they have spread to the CSF 6 …”
mentioning
confidence: 99%
“…Intriguingly, Herrera et al describe how cortisol, a stress hormone, promotes breast to brain metastasis through the blood-CSF barrier. 5 Moreover, Remsik et al demonstrate that breast and lung tumor cells adopt a two-phenotypic state in in leptomeningeal disease when they have spread to the CSF. 6 Finally, given the global impact of COVID-19 on cancer patients, this special issue would be a remiss if it failed to address how it impacts patients with brain metastases.…”
mentioning
confidence: 99%